Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
4.92M
-
Shares change
-
+75.9K
-
Total reported value, excl. options
-
$388M
-
Value change
-
+$6.16M
-
Put/Call ratio
-
0.32
-
Number of buys
-
46
-
Number of sells
-
-44
-
Price
-
$78.77
Significant Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2023
122 filings reported holding PPH - VANECK ETF TRUST - PHARMACEUTCL ETF as of Q2 2023.
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.92M shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (1.12M shares), BANK OF AMERICA CORP /DE/ (1.01M shares), BNP PARIBAS ARBITRAGE, SNC (401K shares), Phoenix Holdings Ltd. (398K shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (344K shares), Avalon Trust Co (286K shares), Prime Capital Investment Advisors, LLC (146K shares), Miller Investment Management, LP (145K shares), VALICENTI ADVISORY SERVICES INC (76.2K shares), and ALERUS FINANCIAL NA (67.7K shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.